Correlation Between IShares SP and Innovator IBD

Can any of the company-specific risk be diversified away by investing in both IShares SP and Innovator IBD at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares SP and Innovator IBD into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between iShares SP Mid Cap and Innovator IBD 50, you can compare the effects of market volatilities on IShares SP and Innovator IBD and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares SP with a short position of Innovator IBD. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares SP and Innovator IBD.

Diversification Opportunities for IShares SP and Innovator IBD

0.82

Correlation Coefficient

IShares SP  Innovator IBD

Very poor diversification

The 3 months correlation between IShares and Innovator is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding iShares SP Mid Cap and Innovator IBD 50 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovator IBD 50 and IShares SP is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares SP Mid Cap are associated (or correlated) with Innovator IBD. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovator IBD 50 has no effect on the direction of IShares SP i.e., IShares SP and Innovator IBD go up and down completely randomly.

Pair Corralation between IShares SP and Innovator IBD

Considering the 90-day investment horizon iShares SP Mid Cap is expected to under-perform the Innovator IBD. But the etf apears to be less risky and, when comparing its historical volatility, iShares SP Mid Cap is 2.03 times less risky than Innovator IBD. The etf trades about -0.11 of its potential returns per unit of risk. The Innovator IBD 50 is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest  2,912  in Innovator IBD 50 on December 30, 2024 and sell it today you would lose (188.00) from holding Innovator IBD 50 or give up 6.46% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

iShares SP Mid Cap  vs.  Innovator IBD 50

iShares SP Mid

Risk-Adjusted Performance

Very Weak

Over the last 90 days iShares SP Mid Cap has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Etf's forward-looking indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the ETF venture institutional investors.

Innovator IBD 50

Risk-Adjusted Performance

Very Weak

Over the last 90 days Innovator IBD 50 has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Innovator IBD is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with IShares SP and Innovator IBD

The main advantage of trading using opposite IShares SP and Innovator IBD positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares SP position performs unexpectedly, Innovator IBD can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovator IBD will offset losses from the drop in Innovator IBD's long position.

The idea behind iShares SP Mid Cap and Innovator IBD 50 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.